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The aim of present study was to determine the antipsoriatic activity of newly formulated O/W creams of methanolic extract of
Cassia tora L. leaves by using ultraviolet-B-induced psoriasis in rat. The plant Cassia tora L. is traditionally claimed to be useful in
thetreatmentofanumberofskindiseases.However,therearenoestablishedscientiﬁcreportsforitsantipsoriaticactivity.Methan-
olic Cassia tora L. leaves extract was used to prepare various concentrations of O/W creams and tested for acute dermal toxicity
study. The diﬀerent O/W creams showed good physical characteristics and passed the sensitivity, irritation, grittiness and bleeding
test. The results of acute dermal toxicity showed that the creams were safe up to the dose of 2000mg/kg. In case of psoriasis model,
histopathological analysis revealed that there were absence of Munro’s microabscess, elongation of rete ridges, and capillary loop
dilation in the section in Test 2 (0.1%) and standard group. O/W creams and methanolic extract of Cassia tora L. leaves exhibited
signiﬁcant reduction in percentage of relative epidermal thickness and spleen index as compared to positive control. We concluded
that topical O/W creams and crude extract containing methanolic extract of Cassia tora L. leaves have potent antipsoriatic activity
in ultraviolet-B-induced psoriasis in rat.
1.Introduction
Psoriasis is a chronic, recurrent, inﬂammatory skin disease
thataﬀects2-3%ofthepopulationworldwideandcausessig-
niﬁcantmorbidityandmortality.Classiclesionisawell-mar-
ginated, redness of the skin due to pathological changes, ery-
thematous plaque with silvery-white surface scale, mainly
distributed into extensor surfaces (knees, elbows, buttocks)
and may also involve palms and scalp. Associated ﬁndings
alsoincludepsoriaticarthriticandnailchanges.Therearein-
ﬂammation, hyperproliferation of the epidermis, and vascu-
lar alterations which lead to the redness. Its exact etiology is
unknown, but it is generally believed to be a complex auto-
immune inﬂammatory disease with a genetic basis [1]. His-
tologically, psoriasis is characterized by acanthosis (thick-
ened epidermis) and parakeratosis (nucleated cells in stra-
tum corneum) and has been described as showing benign
hyperplasia. The dermal blood vessels are abnormally tortu-
ous and dilated, and lymphocytic inﬁltration is frequently
seen in the dermis and occasionally in the epidermis [2].
Therefore, some eﬀective therapies appear to act as antipro-
liferative agents and diminished rates of either epidermal
DNA synthesis, mitosis or both. Treatment of psoriasis
includes topical, systemic, biological, and phototherapy [3].
But these therapies have many side eﬀects. So, there is re-
quirement of an alternative therapy like natural remedies.
Herbal extract is used to prepare cosmetic prepara-
tions to treat diﬀerent skin disorders, augmenting beauty.
Herbal extracts provide an idea to develop new herbal
formulation for hyperpigmentation. Topical creams are
used to enhance the solubility and bioavailability of ther-
apeutic drugs. The plant Cassia tora L. (Caesalpiniaceae)
is traditionally claimed to be useful in the treatment of
Psoriasis and other skin diseases [4, 5]. Cassia tora L. leaves
enriched in glycosides and also containing aloe-emodin
may be beneﬁcial for the skin diseases [6]. However, there
are no established scientiﬁc reports for its antipsoriatic
activity. Hence, the plant Cassia tora L. has been chosen
to establish scientiﬁc data for its traditional claim as
antipsoriatic.2 ISRN Dermatology
2. MaterialsandMethods
2.1. Chemicals. Standard (Tretinoin-0.05%) cream was ob-
tainedfromEthnorPharma.Diethyletherwasobtainedfrom
Rankem, India. Other ingredients such as light liquid para-
ﬃn (Astron), cetostearyl alcohol (Chemdyes), propylene gly-
col (Nomex), white soft paraﬃn (Nomex), butyl hydroxyl
toluene (Rankem), benzyl alcohol (Chemdyes), disodium
EDTA (Rankem), isopropyl myristate (FD Fine Chemicals),
and dibasic potassium phosphate (Rankem) were used to
prepare O/W creams. For histopathological analysis, for-
malin (Merck), hematoxylin (Span Diagnostics), and eosin
(Span Diagnostics) were used.
2.2. Plant Material. Leaves of Cassia tora L. (Cesalpinaceae)
were collected from Dabhoi, Dist. Vadodara, Gujarat, India
and authenticated by Profssor Dr. P. S. Nagar, Department
of Botany, The Maharaja Sayajirao University of Baroda,
Vadodara, Gujarat, India. The voucher specimen (03PG768,
Niraj) has been deposited in the herbarium section of the
Botany Department, The Mahararaja Sayaji Rao University
of Baroda, Vadodara, Gujarat for future and further refer-
ence. The leaves were dried in shade and crushed in the
grinder, coarse powder used for extraction.
2.3. Preparation of Extracts. The methanolic extract was pre-
p a r e db yc o l dm a c e r a t i o nm e t h o d[ 7] by taking 200g of
powdered leaves and extracting with 600mL of methanol for
4 days. Extract was ﬁltered; ﬁltrate was evaporated, using a
rotaryevaporatorunderreducedpressuretodryness.Theex-
tract was used to prepare diﬀerent concentration of O/W
creams.
2.4. Formulation Development. Aqueous phase consisting of
water (q.s) was heated to the temperature (70 ± 5◦C) and
then add disodium EDTA (0.01%), butyl hydroxyl toluene
(0.001%), dibasic potassium phosphate (0.2%) in it. Then
Cassia tora L. extract (0.05%, 0.1%, and 0.2%) was mixed in
benzyl alcohol (1%) and added in it. After that, oily phase
was added to the aqueous phase with continuous stirring at
slow speed for 1 hour and slowly decrease temperature and
mean while add isopropyl myristate (4%) in the mixtures of
both phases. O/W creams were prepared by the addition of
oily phase to the aqueous phase with continuous agitation.
Oily phase consisted of light liquid paraﬃn (8%), cetostearyl
alcohol (10%), propylene glycol (5%), glycerin (5%), white
soft paraﬃn wax (12%), polyethylene glycol 4000 (5%),
tween 80 (5.33%), and butyl hydroxyl anisole (0.001%). The
prepared creams were transferred into wide mouth contain-
ers and stored in cool place. Base was also prepared by the
same above method and with same ingredients but without
Cassia tora L. extracts.
3. Evaluationof O/W Creams[8]
3.1. Physical Evaluation
(1) Color.
(2) Odour.
(3) Form of physical state.
(4) pH: pH of the prepared formulation was measured
using digital pH meter.
(5) Net Content: Weigh the packed product then weigh
without product. The diﬀerence of weight gives net
content weight.
Sensitivity Test. It is tested by “Patch test.” Apply product on
1cm 2 patch of skin; if there is no any inﬂammation or rashes
then it is considered as free from sensitivity.
Irritation Test. It is carried out by applying product on the
skin for 10 minutes. If there is no irritation then it is con-
sidered as non-irritating product.
Grittiness. Apinchofproductisrubbedonskinandthenob-
served with magnifying glass; if it is free from rashes or eru-
ption then it is considered as free from grittiness.
BleedingTest. Suchtypeofevaluationiscarriedoutforsemi-
solid preparation. The products are kept frequently for a per-
iod of time alternatively in fridge and at room temperature
then bleeding of liquid is observed; if no liquid phase is omit
out then it is considered as stable product for climatic con-
ditions.
Stability Studies. The International Conference on Harmo-
nization (ICH) harmonized tripartite guidelines on stability
testing of new drug substance and product was issued on
October 27, 1993. The formulated O/W creams and cream
base were ﬁlled in the wide mouth containers and stored at
40◦C ± 2◦C/75% RH ± 5% RH for a period of three months.
Animals. Adult albino male mice (weight: approx. 25–27g.)
wereusedfortheexperiment.AnimalswerekeptintheShree
Dhanvantary Pharmaceutical Analysis and Research Centre,
Kim,SuratafterapprovalfromtheInstitutionalAnimalEthi-
calCommittee(Reg.no.1103/abc/07/CPCSEA),werehoused
inpolypropylenemousecagesas3animalswillbehousedper
cageandricehuskwillbeusedasthebeddingmaterialwitha
12h light-dark cycle, at temperature of 22 ± 02◦C, humidity
30–70%,andkeptlaboratorymousepelletfeed(PranavAgro
Ltd.) and pure drinking water will be supplied ad libitum.
Theanimalswillbeacclimatizedtothelaboratoryconditions
foraminimumperiodofsevendayspriortocommencement
of treatment.
Acute Dermal Toxicity Study. The acute dermal toxicity test
(LD50) of cream was determined according to the OECD
guidelines no. 402 (Organization for Economic Corporation
and Development) [9]. Adult Wistar rats (approx. 250–
3 0 0g . )o fe i t h e rs e xw e r eu s e d .A p p r o x i m a t e l y2 4h o u r sb e -
fore the test, fur should be removed from the dorsal area
of the trunk of the test animals by clipping of shaving. Not
less than 10% of the body surface area should be clear for
the application of the test substance. Starting dose of
2000mg/kg (topically) of cream was given to three groupsISRN Dermatology 3
(n = 6) each. Cream should be held in contact with the skin
with a porous gauze dressing and non-irritating tape
throughout a 24-hour exposure period. The treated animals
were monitored for 14 days for changes in fur, eyes, behavior,
and toxic reactions. The cream was safe up to the dose of
2000mg/kg and from results suitable dose was chosen for
each activity in each cream for further experimentation.
4. Evaluationof AntipsoriaticActivity
inUV-B InducedPsoriasisinRats[10]
4.1. Assessment of Diﬀerent Formulations and Extract on UV-
B-Induced Psoriatic Rats. The animals were treated with res-
pective doses of diﬀerent concentrations of O/W creams
(Test1—0.05%,Test2—0.1%,Test3—0.2%),standard(Tre-
tinoin-0.05%), cream base, and crude extract applied topi-
cally(single dose) during whole treatment. The animals were
divided into seven groups as follows.
Group 1: Positive control.
Group 2: Standard (Tretinoin-0.05%) cream (topi-
cal).
Group 3: Test 1 (0.05%) cream (topical).
Group 4: Test 2 (0.1%) cream (topical).
Group 5: Test 3 (0.2%) cream (topical).
Group 6: Cream base (topical).
Group 7: Extract (topical).
Wistarrats(male,300g)wereselectedanddividedintoseven
groups. Hair on the dorsal skin was carefully shaved. Test
creams were applied topically on the dorsal part of the skin
exposed to radiation. An area (1.5–2.5cm) on one side of the
ﬂank is irradiated for 15min (1.5J/cm2) at a vertical distan-
ceof 20cm with UV-Blamps. A biphasic erythemais observ-
ed. The second phase of erythema starts 6h after the irradia-
tion and gradually increases, peaking between 24 and 48h.
Thecolorisbrownish-red,andthereactionisconﬁnedtothe
exposed area with sharp boundary. By 48–72h after irradia-
tion,dark-brownscaleisformedontheerythematouslesion.
The irradiated rats are sacriﬁced after various time intervals
by decapitation under ether anesthesia. Skin biopsies are
taken immediately, ﬁxed in 10% formalin, and embedded in
paraﬃn. Tissue sections (4µm thick) are stained with hema-
toxylin and eosin.
4.2. Histopathological Examination.
(1) Sections were examined for presence of Munro’s
microabscesss,elongationofreteridges,andcapillary
loop dilation by direct microscopy.
(2) It was also examined the vertical epidermal thickness
betweenthedermoepidermaljunctionandthelowest
part of the stratum corneum (n = 3m e a s u r e m e n t s
per scale, n = 3 scales per animal, n = 6T h ep e r -
centage relative epidermal thickness of all the groups
was calculated in comparison to the positive control
group (100%; n = 54 measurements per treatment).
4.3. Immunological Analysis
Spleen Index. Spleen index was determined from the weight
of the spleen of the mice surviving up to 10 days. On the 10th
day of treatment, 6 mice from each of the seven groups were
sacriﬁced and the spleens were recovered and weighed. The
results are expressed as the organ index using the formula:
weight of spleen (g)/body weight (g) × 100.
Statistical Analysis. All the experimental results were ex-
pressed as mean ± SEM. For statistical comparisons, explo-
rative probabilities were obtained by the analysis of variance
(ANOVA) followed by Dunnett’s multiple comparison test
using GraphPad Prism 5 (GraphPad software, Inc).
5. Results and Discussion
5.1. Evaluation of Cream. Three diﬀerent concentrations of
O/W creams (Test 1–0.05%, Test 2–0.1%, and Test 3–0.2%)
were prepared to evaluate antipsoriatic activity. Numbers
of parameters were performed to evaluate O/W creams.
Physical evaluation revealed that creams having light green
colour, characteristic odour, semisolid in nature, and pH
ranged from 6.5 to 7. They passed the sensitivity test, irrita-
tion test, grittiness, and bleeding test. Stability of creams
(base and formulation) was evaluated on 40◦C ± 2◦C/75%,
RH ± 5% RH for a period of three months. No phase se-
paration was observed during the stability study of creams.
No liquefaction is observed throughout the study period of
three months.
5.2. Acute Dermal Toxicity Study. The acute dermal toxicity
test (LD50) of creams was determined according to the
OECD guidelines no. 402 (Organization for Economic Cor-
poration and Development). The creams were safe up to the
dose of 2000mg/kg. There were no changes in fur, eyes, and
behavior of treated animals as well as no toxic reactions
determined and from results suitable dose (250mg (0.05%),
500mg (0.1%), and 1000mg (0.2%)) was chosen for each
activity in each cream for further in vivo studies.
5.3. Evaluation of Antipsoriatic Activity. Screening of antip-
soriatic activity was carried out by topical application of dif-
ferentconcentrationofO/Wcreams,creambase,methanolic
extract of Cassia tora L. leaves, and Standard (Retino-A (Tre-
tinoin cream-0.05%)) by using ultraviolet-B-induced psori-
asis in rat.
5.4. Histopathological Examination. Histopathologically,
numbers of features are observed in fully developed lesions
inpsoriasissuchasMunro’smicroabscess,regularelongation
of rete ridges, and capillary loop dilation which are shown in
Table 1 and Figure 1.
In case of positive control group, section showed regular
elongation of rete ridges, capillary loop dilation with min-
imal grade lesion of diagnostic Munro’s microabscess and
marked increase in relative epidermal thickness as compared
to other groups. In case of Standard group, there was4 ISRN Dermatology
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Figure 1: Eﬀe c to fd i ﬀerent formulations on histopathological features on U.V.-B-induced psoriasis in rats.ISRN Dermatology 5
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Figure 2: Eﬀect of diﬀerent formulations on relative epidermal
thickness on U.V.-B induced psoriasis in rats.
Table 1: Eﬀect of diﬀerent formulations on Histopathological fea-
tures on U.V.-B-induced psoriasis in rats.
Treatment Munro’s
microabscess
Elongation of
rete ridges
Capillary
loop dilation
Positive control + +++ ++
Standard −− −
Test 1 − ++
Test 2 −− −
Test 3 − + −
Cream base + ++ +
Extract − + −
Notes. + mild or slight grade lesion; ++ moderate grade lesion; +++ severe
grade lesion; − no lesion in.
absence of Munro’s microabscess, capillary loop dilation
along with elongation of rete ridges in the section showing
good therapeutic eﬀects. In case of Test 1 group, there was
slight decrease in elongation of rete ridges, minimal grade
lesion of Munro’s microabscess along with capillary loop
dilation in the section. In Test 2 group, there was no lesion of
Munro’s microabscess, capillary loop dilation along with
elongation of rete ridges in the section of skin of rats. In case
ofTest3group,therewasdecreaseinelongationofreteridges
and absence of Munro’s microabsces as well as capillary loop
dilation. Cream-base-treated group showed mild grade
lesions of elongation of rete ridges and minimal grade lesion
of Munro’s microabscess as well as capillary loop dilation.
Extract treated group showed absence of Munro’s microab-
scess and capillary loop dilation and minimal grade lesion of
elongation of rete ridges.
Table 2: Eﬀect of diﬀerent formulations on Relative Epidermal
thickness on U.V.-B-induced psoriasis in rats.
Sr. no. Treatment (topical)
% relative epidermal
thickness (µm)
Mean ± SEM
(1) Positive control 100 ±35.77
(2) Standard 20.17 ±4.99
∗∗∗
(3) Test 1 40.92 ±5.39
∗∗∗
(4) Test 2 18.82 ±6.69
∗∗∗
(5) Test 3 20.93 ±6.39
∗∗∗
(6) Cream base 35.99 ±9.57
∗∗∗
(7) Extract 20.94 ±9.26
∗∗∗
Notes. Each value represents Mean ± SEM, n = 6, ∗∗∗P<0.001 compared
to Positive control group. One-way ANOVA followed by Dunnett’s test.
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Figure 3: Eﬀect of diﬀerent formulations on spleen index on U.V.-
B-induced psoriasis in rats.
5.5. Relative Epidermal Thickness. In comparison to Positive
control group, all other groups led to signiﬁcantly decreased
relative epidermal thickness. Statistical analysis for the rela-
tive epidermal thickness revealed the following range of ef-
ﬁcaciesintheinductionofepidermaldiﬀerentiation:Test2>
Standard > Test 3 > Extract > Cream base > Test 1 > Positive
Control. The results of epidermal thickness are presented in
the Table 2 and Figure 2.
5.6. Immunological Analysis
5.6.1. Spleen Index. In comparison to positive control group,
all other groups led to signiﬁcantly decreased spleen index.
The eﬀect of diﬀerent formulations on spleen index is shown
in Table 3 and Figure 3.6 ISRN Dermatology
Table 3: Eﬀe c to fd i ﬀerent formulations on spleen index on U.V.-
B-induced psoriasis in rats.
Sr. no. Treatment (topical) % spleen index
Mean ± SEM
(1) Positive control 0.4833 ±0.03
(2) Standard 0.3550 ±0.02
∗∗
(3) Test 1 0.4033 ±0.03
(4) Test 2 0.3533 ±0.02
∗∗
(5) Test 3 0.3880 ±0.02
∗
(6) Cream base 0.4383 ±0.01
(7) Extract 0.3750 ±0.01
∗∗
Notes. Each value represents Mean ± SEM, n = 6, ∗P<0.05; ∗∗P<
0.01 compared to Positive control group. One-way ANOVA followed by
Dunnett’s test.
6. Conclusion
From the preliminary study we concluded that stable topical
O/W creams containing methanolic extract of Cassia tora L.
leaves signiﬁcantly and dose dependently decreased in the
relative epidermal thickness of animal skin as well as other
histopathological features and also suppressed spleen index
ininvivostudies.TopicalO/Wcreamsandcrudeextractcon-
taining methanolic extract of Cassia tora L. leaves have
potent antipsoriatic activity. The present investigation aims
at the development of potent phytomedicine for treatment
of psoriasis from the Cassia tora L. plant.
Conﬂict of Interests
The authors declare no conﬂict of interests.
References
[1] M. A. Lowes, A. M. Bowcock, and J. G. Krueger, “Pathogenesis
and therapy of psoriasis,” Nature, vol. 445, no. 7130, pp. 866–
873, 2007.
[2] N. J. Lowe, “Psoriasis therapy: a current perspective,” Western
Journal of Medicine, vol. 139, no. 2, pp. 184–189, 1983.
[3] M. Lebwohl, P. T. Ting, and J. Y. M. Koo, “Psoriasis treatment:
traditional therapy,” Annals of the Rheumatic Diseases, vol. 64,
no. 2, pp. ii83–ii86, 2005.
[4] C. P. Khare, Indian Medicinal Plants: An Illustrated Dictionary,
Springer, Berlin, Germany, 2007.
[ 5 ]J .A .D u k e ,Handbook of Medicinal Herbs, CRC Press, Florida,
Fla, USA, 2nd edition, 2002.
[ 6 ]T .K .M a i t y ,S .C .M a n d a l ,T .B h a k t a ,M .P a l ,a n dB .P .S a h a ,
“Metabolism of 1,8-dihydroxy 3-hydroxy methyl anthraqui-
none (Aloe-emodin) isolated from the leaves of Cassia tora in
albinorats,”PhytotherapyResearch,vol.15,no.5,pp.459–460,
2001.
[ 7 ] S .S .H a n d a ,S .P r e e t ,S .K h a n u j a ,G .L o n g o ,a n dD .D .R a k e s h ,
Extraction Technologies for Medicinal and Aromatic Plants,
InternationalCentreforScienceandHighTechnology,Trieste,
Italy, 2008.
[8] S. Saraf and S. Saraf, Cosmetics: A Practical Manual, Pharma
Med Press, Hyderabad, India, 2nd edition, 2009.
[9] OECD, Test No. 402: Acute Dermal Toxicity, OECD Guidelines
for Testing of Chemicals, Section 4, OECD Publishing, Paris,
France, 1987.
[10] H. Nakaguma, T. Kambara, and T. Yamamoto, “Rat ultraviolet
ray B photodermatitis: An experimental model of psoriasis
vulgaris,” International Journal of Experimental Pathology, vol.
76, no. 1, pp. 65–73, 1995.